Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Nature Reviews. Gastroenterology & Hepatology
|
July 31, 2013
NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
June 26, 2012
Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle
Dawn M Torres, Stephen A Harrison
Current Treatment Options in Gastroenterology
|
January 29, 2008
Current treatments in nonalcoholic steatohepatitis
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
September 24, 2013
Small steps toward a better treatment for chronic hepatitis C infection: mericitabine, pegylated interferon, and ribavirin in the PROPEL and JUMP-C trials
Dawn M Torres, Stephen A Harrison
Seminars in Liver Disease
|
March 16, 2012
Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
January 8, 2015
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis
Dawn M Torres, Stephen A Harrison
The American Journal of Gastroenterology
|
May 16, 2008
HCV replication and statin pleotropism: an adjuvant treatment panacea?
Dawn M Torres, Stephen A Harrison
Gastroenterology
|
May 13, 2008
Diagnosis and therapy of nonalcoholic steatohepatitis
Dawn M Torres, Stephen A Harrison
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 2, 2013
Noninvasive methods of assessing nonalcoholic fatty liver disease: what the clinician needs to know
Dawn M Torres, Stephen A Harrison
Gastroenterology
|
March 5, 2013
Is it time to write a prescription for coffee? Coffee and liver disease
Dawn M Torres, Stephen A Harrison
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Nature Reviews. Gastroenterology & Hepatology
|
July 31, 2013
NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
June 26, 2012
Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle
Dawn M Torres, Stephen A Harrison
Current Treatment Options in Gastroenterology
|
January 29, 2008
Current treatments in nonalcoholic steatohepatitis
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
September 24, 2013
Small steps toward a better treatment for chronic hepatitis C infection: mericitabine, pegylated interferon, and ribavirin in the PROPEL and JUMP-C trials
Dawn M Torres, Stephen A Harrison
Seminars in Liver Disease
|
March 16, 2012
Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)
|
January 8, 2015
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis
Dawn M Torres, Stephen A Harrison
The American Journal of Gastroenterology
|
May 16, 2008
HCV replication and statin pleotropism: an adjuvant treatment panacea?
Dawn M Torres, Stephen A Harrison
Gastroenterology
|
May 13, 2008
Diagnosis and therapy of nonalcoholic steatohepatitis
Dawn M Torres, Stephen A Harrison
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 2, 2013
Noninvasive methods of assessing nonalcoholic fatty liver disease: what the clinician needs to know
Dawn M Torres, Stephen A Harrison
Gastroenterology
|
March 5, 2013
Is it time to write a prescription for coffee? Coffee and liver disease
Dawn M Torres, Stephen A Harrison
Page
of 4